Globus Medical, Inc. reported $3.14B of revenue over the trailing twelve months, +20% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $3.14B (to Q2 2026). Net income: $535M, trailing twelve months to Q2 2026. Free cash flow: $756M, trailing twelve months to Q2 2026. Operating margin: 20%, trailing twelve months to Q2 2026.

GMEDGlobus Medical, Inc.

Healthcare

$74.65+34% 1Y

$74.65

$55.1052 weeks$96.82

GMED as reported

Globus Medical, Inc. reported $3.14B of revenue over the trailing twelve months, +20% on the year before. 10 reported series are charted on this page, each one as filed.

$3.14B

Revenue, trailing twelve months · to Q2 2026 · +20% against the twelve months before

Net income: $535M
Net income · +50% year on year · trailing twelve months to Q2 2026
Free cash flow: $756M
Free cash flow · +43% year on year · trailing twelve months to Q2 2026
Operating margin: 20%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for GMED, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$3.14B	+20%	Q2 2026
Net income	$535M	+50%	Q2 2026
EPS	$3.90	+50%	Q2 2026
Gross margin	69%	n/a	Q2 2026
Operating margin	20%	n/a	Q2 2026
Net margin	17%	n/a	Q2 2026
ROE	11%	n/a	Q2 2026
ROA	9.8%	n/a	Q2 2026
Free cash flow	$756M	+43%	Q2 2026
P/E	19.1	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.